Literature DB >> 21889884

Liver X receptor negatively regulates fibroblast growth factor 21 in the fatty liver induced by cholesterol-enriched diet.

Takashi Uebanso1, Yutaka Taketani, Hironori Yamamoto, Kikuko Amo, Sarasa Tanaka, Hidekazu Arai, Yuichiro Takei, Masashi Masuda, Hisami Yamanaka-Okumura, Eiji Takeda.   

Abstract

Cholesterol homeostasis is regulated by the liver X receptor (LXR) at the transcriptional level, but it remains unknown whether LXR can affect expression levels of intrahepatic lipolysis related gene. Recent evidence has demonstrated that fibroblast growth factor 21 (FGF21) regulates hepatic lipolysis and fatty acid utilization. In the present study, we examined the role of LXR in FGF21 gene expression associated with regulation of cross-talk signals between cholesterol and triglyceride metabolism in the liver. An in vivo cholesterol feeding test revealed that intake of excess cholesterol increased cholesterol catabolism related gene expression as well as fatty-acid biosynthesis related gene expression. Moreover, the accumulated cholesterol suppressed FGF21 and hormone-sensitive lipase (HSL) gene expression. After 15-day cholesterol feeding, hepatic triglyceride concentrations were negatively correlated with expression levels of the FGF21 and HSL genes in the liver. An LXR agonist (TO-901317) repressed the FGF21 gene expression in mouse primary hepatocytes and HepG2 cells. A promoter deletion study and electrophoretic mobility shift assay revealed that the human FGF21 promoter has at least one LXR response element located from -37 to -22 bp. In summary, LXR represses FGF21 gene expression at the transcription level and might suppress lipolysis and lipid utilization to protect the liver from excess accumulation of toxic cholesterol.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889884     DOI: 10.1016/j.jnutbio.2011.03.023

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  17 in total

1.  Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice.

Authors:  Amena Archer; Nicolas Venteclef; Agneta Mode; Matteo Pedrelli; Chiara Gabbi; Karine Clément; Paolo Parini; Jan-Åke Gustafsson; Marion Korach-André
Journal:  Mol Endocrinol       Date:  2012-10-16

2.  Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein.

Authors:  Xin Tong; Deqiang Zhang; Katie Buelow; Anirvan Guha; Blake Arthurs; Hugh J M Brady; Lei Yin
Journal:  J Biol Chem       Date:  2013-01-02       Impact factor: 5.157

3.  FGF21 mediates the lipid metabolism response to amino acid starvation.

Authors:  Ana Luísa De Sousa-Coelho; Joana Relat; Elayne Hondares; Albert Pérez-Martí; Francesc Ribas; Francesc Villarroya; Pedro F Marrero; Diego Haro
Journal:  J Lipid Res       Date:  2013-05-09       Impact factor: 5.922

4.  1,8-Cineole Ameliorates Steatosis of Pten Liver Specific KO Mice via Akt Inactivation.

Authors:  Soichiro Murata; Koichi Ogawa; Takashi Matsuzaka; Mitsuru Chiba; Ken Nakayama; Kenichi Iwasaki; Tomohiro Kurokawa; Naoki Sano; Tomohito Tanoi; Nobuhiro Ohkohchi
Journal:  Int J Mol Sci       Date:  2015-05-27       Impact factor: 5.923

Review 5.  Stressed Liver and Muscle Call on Adipocytes with FGF21.

Authors:  Yongde Luo; Wallace L McKeehan
Journal:  Front Endocrinol (Lausanne)       Date:  2013-12-18       Impact factor: 5.555

6.  Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress.

Authors:  Chaofeng Yang; Weiqin Lu; Tao Lin; Pan You; Min Ye; Yanqing Huang; Xianhan Jiang; Cong Wang; Fen Wang; Mong-Hong Lee; Sai-Ching J Yeung; Randy L Johnson; Chongjuan Wei; Robert Y Tsai; Marsha L Frazier; Wallace L McKeehan; Yongde Luo
Journal:  BMC Gastroenterol       Date:  2013-04-17       Impact factor: 3.067

7.  Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.

Authors:  Sasmita Tripathy; Kelli A Lytle; Robert D Stevens; James R Bain; Christopher B Newgard; Andrew S Greenberg; Li-Shin Huang; Donald B Jump
Journal:  J Lipid Res       Date:  2014-05-09       Impact factor: 6.676

Review 8.  Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD.

Authors:  Takeshi Inagaki
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-23       Impact factor: 5.555

9.  Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts.

Authors:  Vanlata Patel; Raghu Adya; Jing Chen; Manjunath Ramanjaneya; Muhammad F Bari; Sunil K Bhudia; Edward W Hillhouse; Bee K Tan; Harpal S Randeva
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.

Authors:  Alexandra Montagner; Arnaud Polizzi; Edwin Fouché; Simon Ducheix; Yannick Lippi; Frédéric Lasserre; Valentin Barquissau; Marion Régnier; Céline Lukowicz; Fadila Benhamed; Alison Iroz; Justine Bertrand-Michel; Talal Al Saati; Patricia Cano; Laila Mselli-Lakhal; Gilles Mithieux; Fabienne Rajas; Sandrine Lagarrigue; Thierry Pineau; Nicolas Loiseau; Catherine Postic; Dominique Langin; Walter Wahli; Hervé Guillou
Journal:  Gut       Date:  2016-02-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.